This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of West Pharmaceutical Services Inc. (WST) advanced 1.33% to $316.31 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&amp;P 500 Index falling 0.74% to 7,553.68 and Dow Jones Industrial Average falling 1.21% to 50,687.07.
The stock's rise snapped a two-day losing streak.
West Pharmaceutical Services Inc. closed 4.40% below its 52-week high of $330.88, which the company achieved on May 11th.
The stock outperformed some of its competitors Wednesday, as Abbott Laboratories (ABT) rose 0.02% to $86.99, Becton Dickinson &amp; Co. (BDX) rose 0.82% to $145.61, and Baxter International Inc. (BAX) fell 0.75% to $18.54.
Trading volume (632,495) remained 239,446 below its 50-day average volume of 871,941.
Data source: Dow Jones Market Data, FactSet. Data compiled June 3, 2026.
This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
06-03-26 1705ET

West Pharmaceutical Services Inc. (WST) stock rose 1.33% to $316.31, outperforming competitors like Abbott Laboratories and Becton Dickinson during a broader market decline. The gain ended a two-day losing streak, though shares remain 4.40% below their 52-week high. Trading volume was below the 50-day average.

MarketWatch Automated

West Pharmaceutical

S&P 500

West Pharmaceutical Services Inc. Stock Outperforms Competitors On Strong Trading Day